|

OPB-101 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Outpace Bio, Inc.1

Indications

  • Ovarian Cancer Recurrent1
  • Platinum-resistant Ovarian Cancer1
  • Ovarian Cancer1
  • Cancer1

Detroit, Michigan1 trial

A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

Karmanos Cancer Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.